Scientists at Hesperos Inc. use the human-on-a-chip technology to study the effects of a repeated overdose of opioids and to test new drugs.

Computer scientist, biochemist and medical scientist Professor Dr. Dr. Thomas Hartung from Johns Hopkins University in Baltimore and the University of Konstanz and biochemist and toxicologist Professor Dr. Marcel Leist, also from the University of Konstanz, have been selected to receive the Ursula M. Händel Animal Welfare Prize by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation).

In a project called "VISION", scientists from Saarland are developing and validating an in vitro/in silico analysis platform, especially for inhalation toxicological studies. Institutions of Saarland University and the Fraunhofer Institute for Biomedical Engineering (IBMT) are involved in this project which is funded by the federal ministry of Education and Research (BMBF).

Scientists from the Ludwig Maximilian University of Munich and the University Hospital of Ulm have used cell cultures to investigate the mechanism by which a SARS CoV2 virus protein can block the entire host's own protein production.

On July 10, Asahi Group Holdings, Ltd. (Asahi Group) which owns Asahi Breweries, Asahi Soft Drinks, and Asahi Group Foods responded to JAVA's request to ban animal testing.

The project is divided into six thematic areas, in which research is also carried out to study SARS-CoV-2 infection using 2- and 3-dimensional human tissue models and alternative models to animal experiments.

Israel: Drug testing with 3D hearts

Wednesday, 15 July 2020 13:58

Researchers from the University of Tel Aviv will work together with Bayer to develop and validate an in vitro cardiotoxicity platform for drug screening.

The company Bit Bio is specialized in the deterministic programming of human cells, thereby skipping the time-consuming and inconsistent embryonic development.

The Einstein Foundation in Berlin has approved the preliminary stage of an Einstein Center 3R for the development of alternative methods to animal testing.

South Carolina: In vitro heart attack model

Wednesday, 08 July 2020 09:19

To better understand heart failure and to improve drug testing for patients with heart failure, scientists at the Medical University of South Carolina (MUSC) and from Clemson University have developed a heart attack model in the form of an organoid.